GLP-1s tested for uses beyond weight loss, diabetes
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a …
Viking Therapeutics Inc
Eli Lilly, drugmakers show off weight loss drug data
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Think a friend or colleague should …
Don’t sell Tesla, but stay away from this biotech stock
Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. Tesla : Shares were slightly lower Tuesday. CNBC reported earlier in the day …
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images Novo Nordisk and Eli Lilly have …
Viking Therapeutics weight loss pill shows positive study results
Alexey Krukovsky | Istock | Getty Images Viking Therapeutics shares jumped more than 25% on Tuesday after the company said its experimental weight loss pill showed positive results in a …
First NASH liver disease drug is here, more coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign …
Viking Therapeutics emerges as competitor
Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. Viking …
Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re …
TJX’s quarter delivers and what Cramer hopes to hear from Salesforce
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. U.S. stocks were trending …
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and valuable market, rivals are still eager to join the race. Bank …